The LensAR Laser System by LensAR, Inc., has received FDA clearance for anterior capsulotomy and lens fragmentation during cataract surgery. The system uses a proprietary 3D imaging technology called 3D-CSI (Confocal Structured Illumination) for precise imaging and easier cataract removal.
To date, the system has been used in more than 500 eyes outside of the United States. The first U.S. surgeon to use the system, Louis “Skip” Nichamin, MD, stated the process was “considerably more proficient and seamless” than conventional processes. With FDA clearance, the technology is a step closer to commercialization, according to the company.